Immunomodulatory proteins FIP-gts and chloroquine induce caspase-independent cell death via autophagy for resensitizing cisplatin-resistant urothelial cancer cells.
Identifieur interne : 000D70 ( Main/Exploration ); précédent : 000D69; suivant : 000D71Immunomodulatory proteins FIP-gts and chloroquine induce caspase-independent cell death via autophagy for resensitizing cisplatin-resistant urothelial cancer cells.
Auteurs : I-Lun Hsin [Taïwan] ; Shao-Chuan Wang [Taïwan] ; Jian-Ri Li [Taïwan] ; Tsai-Chun Ciou [Taïwan] ; Chih-Hsien Wu [Taïwan] ; Hung-Ming Wu [Taïwan] ; Jiunn-Liang Ko [Taïwan]Source :
- Phytomedicine : international journal of phytotherapy and phytopharmacology [ 1618-095X ] ; 2016.
Descripteurs français
- KwdFr :
- Apoptose (), Autophagie (), Caspases (métabolisme), Chlorométhyl cétones d'acides aminés (pharmacologie), Chloroquine (administration et posologie), Chloroquine (pharmacologie), Cisplatine (pharmacologie), Cycle cellulaire (), Facteurs immunologiques (pharmacologie), Ganoderma (), Humains, Lignée cellulaire tumorale, Potentiel de membrane mitochondriale (), Protocoles de polychimiothérapie antinéoplasique (pharmacologie), Protéines fongiques (administration et posologie), Protéines fongiques (pharmacologie), Résistance aux médicaments antinéoplasiques (), Survie cellulaire (), Tumeurs urologiques (anatomopathologie), Tumeurs urologiques (traitement médicamenteux).
- MESH :
- administration et posologie : Chloroquine, Protéines fongiques.
- anatomopathologie : Tumeurs urologiques.
- métabolisme : Caspases.
- pharmacologie : Chlorométhyl cétones d'acides aminés, Chloroquine, Cisplatine, Facteurs immunologiques, Protocoles de polychimiothérapie antinéoplasique, Protéines fongiques.
- traitement médicamenteux : Tumeurs urologiques.
- Apoptose, Autophagie, Cycle cellulaire, Ganoderma, Humains, Lignée cellulaire tumorale, Potentiel de membrane mitochondriale, Résistance aux médicaments antinéoplasiques, Survie cellulaire.
English descriptors
- KwdEn :
- Amino Acid Chloromethyl Ketones (pharmacology), Antineoplastic Combined Chemotherapy Protocols (pharmacology), Apoptosis (drug effects), Autophagy (drug effects), Caspases (metabolism), Cell Cycle (drug effects), Cell Line, Tumor, Cell Survival (drug effects), Chloroquine (administration & dosage), Chloroquine (pharmacology), Cisplatin (pharmacology), Drug Resistance, Neoplasm (drug effects), Fungal Proteins (administration & dosage), Fungal Proteins (pharmacology), Ganoderma (chemistry), Humans, Immunologic Factors (pharmacology), Membrane Potential, Mitochondrial (drug effects), Urologic Neoplasms (drug therapy), Urologic Neoplasms (pathology).
- MESH :
- chemical , administration & dosage : Chloroquine, Fungal Proteins.
- chemical , metabolism : Caspases.
- chemical , pharmacology : Amino Acid Chloromethyl Ketones, Chloroquine, Cisplatin, Fungal Proteins, Immunologic Factors.
- chemistry : Ganoderma.
- drug effects : Apoptosis, Autophagy, Cell Cycle, Cell Survival, Drug Resistance, Neoplasm, Membrane Potential, Mitochondrial.
- drug therapy : Urologic Neoplasms.
- pathology : Urologic Neoplasms.
- pharmacology : Antineoplastic Combined Chemotherapy Protocols.
- Cell Line, Tumor, Humans.
Abstract
Chloroquine, a lysosomal inhibitor, is used for malaria, rheumatoid arthritis, and lupus erythematosus therapy. In our previous study, FIP-gts, an immunomodulatory protein from Ganoderma tsugae, inhibited cell viability in lung cancer cells and urothelial cancer cells. Urothelial carcinoma is the most common type of bladder cancer. Cisplatin resistance is an important issue in urothelial carcinoma therapy.
DOI: 10.1016/j.phymed.2016.09.003
PubMed: 27823620
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000189
- to stream PubMed, to step Curation: 000189
- to stream PubMed, to step Checkpoint: 000205
- to stream Ncbi, to step Merge: 000362
- to stream Ncbi, to step Curation: 000362
- to stream Ncbi, to step Checkpoint: 000362
- to stream Main, to step Merge: 000D71
- to stream Main, to step Curation: 000D70
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Immunomodulatory proteins FIP-gts and chloroquine induce caspase-independent cell death via autophagy for resensitizing cisplatin-resistant urothelial cancer cells.</title><author><name sortKey="Hsin, I Lun" sort="Hsin, I Lun" uniqKey="Hsin I" first="I-Lun" last="Hsin">I-Lun Hsin</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Inflammation Research & Drug Development Center, Changhua Christian Hospital, Changhua, Taiwan.</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Inflammation Research & Drug Development Center, Changhua Christian Hospital, Changhua</wicri:regionArea><wicri:noRegion>Changhua</wicri:noRegion></affiliation></author><author><name sortKey="Wang, Shao Chuan" sort="Wang, Shao Chuan" uniqKey="Wang S" first="Shao-Chuan" last="Wang">Shao-Chuan Wang</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Department of Urology, Chung-Shan Medical University Hospital, Taichung, Taiwan; School of Medicine, Chung-Shan Medical University, Taichung, Taiwan.</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Department of Urology, Chung-Shan Medical University Hospital, Taichung, Taiwan; School of Medicine, Chung-Shan Medical University, Taichung</wicri:regionArea><wicri:noRegion>Taichung</wicri:noRegion></affiliation></author><author><name sortKey="Li, Jian Ri" sort="Li, Jian Ri" uniqKey="Li J" first="Jian-Ri" last="Li">Jian-Ri Li</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung</wicri:regionArea><wicri:noRegion>Taichung</wicri:noRegion></affiliation></author><author><name sortKey="Ciou, Tsai Chun" sort="Ciou, Tsai Chun" uniqKey="Ciou T" first="Tsai-Chun" last="Ciou">Tsai-Chun Ciou</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Institute of Medicine, Chung Shan Medical University, Taichung</wicri:regionArea><wicri:noRegion>Taichung</wicri:noRegion></affiliation></author><author><name sortKey="Wu, Chih Hsien" sort="Wu, Chih Hsien" uniqKey="Wu C" first="Chih-Hsien" last="Wu">Chih-Hsien Wu</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Institute of Medicine, Chung Shan Medical University, Taichung</wicri:regionArea><wicri:noRegion>Taichung</wicri:noRegion></affiliation></author><author><name sortKey="Wu, Hung Ming" sort="Wu, Hung Ming" uniqKey="Wu H" first="Hung-Ming" last="Wu">Hung-Ming Wu</name><affiliation wicri:level="1"><nlm:affiliation>Inflammation Research & Drug Development Center, Changhua Christian Hospital, Changhua, Taiwan; Graduate Institute of Acupuncture Science, China Medical University, Taichung, Taiwan; Department of Neurology, Changhua Christian Hospital, Changhua, Taiwan.</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Inflammation Research & Drug Development Center, Changhua Christian Hospital, Changhua, Taiwan; Graduate Institute of Acupuncture Science, China Medical University, Taichung, Taiwan; Department of Neurology, Changhua Christian Hospital, Changhua</wicri:regionArea><wicri:noRegion>Changhua</wicri:noRegion></affiliation></author><author><name sortKey="Ko, Jiunn Liang" sort="Ko, Jiunn Liang" uniqKey="Ko J" first="Jiunn-Liang" last="Ko">Jiunn-Liang Ko</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Department of Urology, Chung-Shan Medical University Hospital, Taichung, Taiwan; School of Medicine, Chung-Shan Medical University, Taichung, Taiwan. Electronic address: jlko1007@gmail.com.</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Department of Urology, Chung-Shan Medical University Hospital, Taichung, Taiwan; School of Medicine, Chung-Shan Medical University, Taichung</wicri:regionArea><wicri:noRegion>Taichung</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27823620</idno><idno type="pmid">27823620</idno><idno type="doi">10.1016/j.phymed.2016.09.003</idno><idno type="wicri:Area/PubMed/Corpus">000189</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000189</idno><idno type="wicri:Area/PubMed/Curation">000189</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000189</idno><idno type="wicri:Area/PubMed/Checkpoint">000205</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000205</idno><idno type="wicri:Area/Ncbi/Merge">000362</idno><idno type="wicri:Area/Ncbi/Curation">000362</idno><idno type="wicri:Area/Ncbi/Checkpoint">000362</idno><idno type="wicri:Area/Main/Merge">000D71</idno><idno type="wicri:Area/Main/Curation">000D70</idno><idno type="wicri:Area/Main/Exploration">000D70</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Immunomodulatory proteins FIP-gts and chloroquine induce caspase-independent cell death via autophagy for resensitizing cisplatin-resistant urothelial cancer cells.</title><author><name sortKey="Hsin, I Lun" sort="Hsin, I Lun" uniqKey="Hsin I" first="I-Lun" last="Hsin">I-Lun Hsin</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Inflammation Research & Drug Development Center, Changhua Christian Hospital, Changhua, Taiwan.</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Inflammation Research & Drug Development Center, Changhua Christian Hospital, Changhua</wicri:regionArea><wicri:noRegion>Changhua</wicri:noRegion></affiliation></author><author><name sortKey="Wang, Shao Chuan" sort="Wang, Shao Chuan" uniqKey="Wang S" first="Shao-Chuan" last="Wang">Shao-Chuan Wang</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Department of Urology, Chung-Shan Medical University Hospital, Taichung, Taiwan; School of Medicine, Chung-Shan Medical University, Taichung, Taiwan.</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Department of Urology, Chung-Shan Medical University Hospital, Taichung, Taiwan; School of Medicine, Chung-Shan Medical University, Taichung</wicri:regionArea><wicri:noRegion>Taichung</wicri:noRegion></affiliation></author><author><name sortKey="Li, Jian Ri" sort="Li, Jian Ri" uniqKey="Li J" first="Jian-Ri" last="Li">Jian-Ri Li</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung</wicri:regionArea><wicri:noRegion>Taichung</wicri:noRegion></affiliation></author><author><name sortKey="Ciou, Tsai Chun" sort="Ciou, Tsai Chun" uniqKey="Ciou T" first="Tsai-Chun" last="Ciou">Tsai-Chun Ciou</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Institute of Medicine, Chung Shan Medical University, Taichung</wicri:regionArea><wicri:noRegion>Taichung</wicri:noRegion></affiliation></author><author><name sortKey="Wu, Chih Hsien" sort="Wu, Chih Hsien" uniqKey="Wu C" first="Chih-Hsien" last="Wu">Chih-Hsien Wu</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Institute of Medicine, Chung Shan Medical University, Taichung</wicri:regionArea><wicri:noRegion>Taichung</wicri:noRegion></affiliation></author><author><name sortKey="Wu, Hung Ming" sort="Wu, Hung Ming" uniqKey="Wu H" first="Hung-Ming" last="Wu">Hung-Ming Wu</name><affiliation wicri:level="1"><nlm:affiliation>Inflammation Research & Drug Development Center, Changhua Christian Hospital, Changhua, Taiwan; Graduate Institute of Acupuncture Science, China Medical University, Taichung, Taiwan; Department of Neurology, Changhua Christian Hospital, Changhua, Taiwan.</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Inflammation Research & Drug Development Center, Changhua Christian Hospital, Changhua, Taiwan; Graduate Institute of Acupuncture Science, China Medical University, Taichung, Taiwan; Department of Neurology, Changhua Christian Hospital, Changhua</wicri:regionArea><wicri:noRegion>Changhua</wicri:noRegion></affiliation></author><author><name sortKey="Ko, Jiunn Liang" sort="Ko, Jiunn Liang" uniqKey="Ko J" first="Jiunn-Liang" last="Ko">Jiunn-Liang Ko</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Department of Urology, Chung-Shan Medical University Hospital, Taichung, Taiwan; School of Medicine, Chung-Shan Medical University, Taichung, Taiwan. Electronic address: jlko1007@gmail.com.</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Department of Urology, Chung-Shan Medical University Hospital, Taichung, Taiwan; School of Medicine, Chung-Shan Medical University, Taichung</wicri:regionArea><wicri:noRegion>Taichung</wicri:noRegion></affiliation></author></analytic><series><title level="j">Phytomedicine : international journal of phytotherapy and phytopharmacology</title><idno type="eISSN">1618-095X</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amino Acid Chloromethyl Ketones (pharmacology)</term><term>Antineoplastic Combined Chemotherapy Protocols (pharmacology)</term><term>Apoptosis (drug effects)</term><term>Autophagy (drug effects)</term><term>Caspases (metabolism)</term><term>Cell Cycle (drug effects)</term><term>Cell Line, Tumor</term><term>Cell Survival (drug effects)</term><term>Chloroquine (administration & dosage)</term><term>Chloroquine (pharmacology)</term><term>Cisplatin (pharmacology)</term><term>Drug Resistance, Neoplasm (drug effects)</term><term>Fungal Proteins (administration & dosage)</term><term>Fungal Proteins (pharmacology)</term><term>Ganoderma (chemistry)</term><term>Humans</term><term>Immunologic Factors (pharmacology)</term><term>Membrane Potential, Mitochondrial (drug effects)</term><term>Urologic Neoplasms (drug therapy)</term><term>Urologic Neoplasms (pathology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Apoptose ()</term><term>Autophagie ()</term><term>Caspases (métabolisme)</term><term>Chlorométhyl cétones d'acides aminés (pharmacologie)</term><term>Chloroquine (administration et posologie)</term><term>Chloroquine (pharmacologie)</term><term>Cisplatine (pharmacologie)</term><term>Cycle cellulaire ()</term><term>Facteurs immunologiques (pharmacologie)</term><term>Ganoderma ()</term><term>Humains</term><term>Lignée cellulaire tumorale</term><term>Potentiel de membrane mitochondriale ()</term><term>Protocoles de polychimiothérapie antinéoplasique (pharmacologie)</term><term>Protéines fongiques (administration et posologie)</term><term>Protéines fongiques (pharmacologie)</term><term>Résistance aux médicaments antinéoplasiques ()</term><term>Survie cellulaire ()</term><term>Tumeurs urologiques (anatomopathologie)</term><term>Tumeurs urologiques (traitement médicamenteux)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Chloroquine</term><term>Fungal Proteins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Caspases</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Amino Acid Chloromethyl Ketones</term><term>Chloroquine</term><term>Cisplatin</term><term>Fungal Proteins</term><term>Immunologic Factors</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Chloroquine</term><term>Protéines fongiques</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Tumeurs urologiques</term></keywords><keywords scheme="MESH" qualifier="chemistry" xml:lang="en"><term>Ganoderma</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Apoptosis</term><term>Autophagy</term><term>Cell Cycle</term><term>Cell Survival</term><term>Drug Resistance, Neoplasm</term><term>Membrane Potential, Mitochondrial</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Urologic Neoplasms</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Caspases</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Urologic Neoplasms</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Chlorométhyl cétones d'acides aminés</term><term>Chloroquine</term><term>Cisplatine</term><term>Facteurs immunologiques</term><term>Protocoles de polychimiothérapie antinéoplasique</term><term>Protéines fongiques</term></keywords><keywords scheme="MESH" qualifier="pharmacology" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Tumeurs urologiques</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Cell Line, Tumor</term><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Apoptose</term><term>Autophagie</term><term>Cycle cellulaire</term><term>Ganoderma</term><term>Humains</term><term>Lignée cellulaire tumorale</term><term>Potentiel de membrane mitochondriale</term><term>Résistance aux médicaments antinéoplasiques</term><term>Survie cellulaire</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Chloroquine, a lysosomal inhibitor, is used for malaria, rheumatoid arthritis, and lupus erythematosus therapy. In our previous study, FIP-gts, an immunomodulatory protein from Ganoderma tsugae, inhibited cell viability in lung cancer cells and urothelial cancer cells. Urothelial carcinoma is the most common type of bladder cancer. Cisplatin resistance is an important issue in urothelial carcinoma therapy.</div></front></TEI><affiliations><list><country><li>Taïwan</li></country></list><tree><country name="Taïwan"><noRegion><name sortKey="Hsin, I Lun" sort="Hsin, I Lun" uniqKey="Hsin I" first="I-Lun" last="Hsin">I-Lun Hsin</name></noRegion><name sortKey="Ciou, Tsai Chun" sort="Ciou, Tsai Chun" uniqKey="Ciou T" first="Tsai-Chun" last="Ciou">Tsai-Chun Ciou</name><name sortKey="Ko, Jiunn Liang" sort="Ko, Jiunn Liang" uniqKey="Ko J" first="Jiunn-Liang" last="Ko">Jiunn-Liang Ko</name><name sortKey="Li, Jian Ri" sort="Li, Jian Ri" uniqKey="Li J" first="Jian-Ri" last="Li">Jian-Ri Li</name><name sortKey="Wang, Shao Chuan" sort="Wang, Shao Chuan" uniqKey="Wang S" first="Shao-Chuan" last="Wang">Shao-Chuan Wang</name><name sortKey="Wu, Chih Hsien" sort="Wu, Chih Hsien" uniqKey="Wu C" first="Chih-Hsien" last="Wu">Chih-Hsien Wu</name><name sortKey="Wu, Hung Ming" sort="Wu, Hung Ming" uniqKey="Wu H" first="Hung-Ming" last="Wu">Hung-Ming Wu</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D70 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D70 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:27823620
|texte= Immunomodulatory proteins FIP-gts and chloroquine induce caspase-independent cell death via autophagy for resensitizing cisplatin-resistant urothelial cancer cells.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27823620" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a ChloroquineV1
| This area was generated with Dilib version V0.6.33. |  |